Cargando…

Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020

This cross-sectional study analyzes trends in Medicare Part D use and spending on oral-targeted drugs for chronic lymphocytic leukemia from 2014 to 2020.

Detalles Bibliográficos
Autores principales:	Cliff, Edward R. Scheffer, Kesselheim, Aaron S., Rome, Benjamin N., Feldman, William B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082405/ https://www.ncbi.nlm.nih.gov/pubmed/37027159 http://dx.doi.org/10.1001/jamanetworkopen.2023.7467

Ejemplares similares

Medicare Spending on Drugs With Accelerated Approval, 2015-2019
por: Rome, Benjamin N., et al.
Publicado: (2021)

Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
por: Kyle, Michael Anne, et al.
Publicado: (2022)

National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019
por: Troy, Aaron, et al.
Publicado: (2021)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis
por: Li, David G, et al.
Publicado: (2019)

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
por: Essa, Mohammed, et al.
Publicado: (2023)

Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018
por: Mafi, John N., et al.
Publicado: (2021)

Prescription Drug Coverage and Spending for Medicare Beneficiaries
por: Poisal, John A., et al.
Publicado: (1999)

Outpatient prescription drug spending by the Medicare population
por: Waldo, Daniel R.
Publicado: (1987)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Trends in and Factors Contributing to the Slowdown in Medicare Spending Growth, 2007-2018
por: Buntin, Melinda B., et al.
Publicado: (2022)

Coverage of New Drugs in Medicare Part D
por: NACI, HUSEYIN, et al.
Publicado: (2022)

State-Level Variation in Medicare Spending
por: Gage, Barbara, et al.
Publicado: (1999)

Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012
por: Hernandez, Inmaculada, et al.
Publicado: (2017)

Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019
por: Tringale, Kathryn R., et al.
Publicado: (2022)

Drug Coverage, Utilization, and Spending by Medicare Beneficiaries with Heart Disease
por: Sharma, Ravi, et al.
Publicado: (2003)

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
por: Rome, Benjamin N., et al.
Publicado: (2021)

Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis
por: Schwartz, Aaron L., et al.
Publicado: (2021)

Trends in medicare spending across strata of resource utilization among older individuals in the United States
por: Wallis, Christopher J.D., et al.
Publicado: (2021)

The impact of weight loss among seniors on Medicare spending
por: Thorpe, Kenneth E, et al.
Publicado: (2013)

Medicare physicians' services: The composition of spending and assignment rates
por: Burney, Ira, et al.
Publicado: (1985)

Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Estimated Annual Spending on Aducanumab in the US Medicare Program
por: Mafi, John N., et al.
Publicado: (2022)

Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study
por: Liu, Michael, et al.
Publicado: (2020)

Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
por: Parikh, Ravi B., et al.
Publicado: (2022)

Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending
por: Metes, Ilinca D., et al.
Publicado: (2019)

Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
por: Kesselheim, Aaron S, et al.
Publicado: (2015)

The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs
por: Bendicksen, Liam, et al.
Publicado: (2022)

DataView: Medicare Spending by State: The Border-Crossing Adjustment
por: Basu, Joy, et al.
Publicado: (1995)

Association of Medicare Spending With Subspecialty Consultation for Elderly Hospitalized Adults
por: Ryskina, Kira L., et al.
Publicado: (2019)

Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study
por: Gyawali, Bishal, et al.
Publicado: (2021)

Trends in orphan drug use and spending among children and adolescents during 2010–2020 in Korea
por: Oh, Jung Yeon, et al.
Publicado: (2022)

Association Between Medicare Star Ratings for Patient Experience and Medicare Spending per Beneficiary for US Hospitals
por: Trzeciak, Stephen, et al.
Publicado: (2017)

Analysis of Prescriptions Dispensed After Death and Associated Medicare Spending Following Reimbursement Policy Changes in Medicare
por: Vouri, Scott M., et al.
Publicado: (2023)

Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market
por: Dean, Emma Boswell, et al.
Publicado: (2021)

Timing of Confirmatory Trials for Drugs Granted Accelerated Approval Based on Surrogate Measures From 2012 to 2021
por: Deshmukh, Anjali D., et al.
Publicado: (2023)

Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D
por: Naci, Huseyin, et al.
Publicado: (2023)

Association of Mental Health Disorders With Health Care Spending in the Medicare Population
por: Figueroa, Jose F., et al.
Publicado: (2020)

Social Determinants of Health and Geographic Variation in Medicare per Beneficiary Spending
por: Zhang, Yongkang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cir95nah62uonlq7g0vkj3frvc